Closing Bell Roundup: Nov. 14th, 2023

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. 

Today is Tuesday, November 14th. I hope you had a great trading session.

Here's what moved the market today:  

Markets 📈

Stocks rallied on Tuesday following the release of October’s CPI report. The S&P 500 [+1.9%], Nasdaq [+2.3%] and Dow [+1.4%] rallied higher, while the small-cap Russell 2K [+5.2%] exploded for a massive gain.  

The CPI report also spurred on the biggest rally in bonds since March. Yields on U.S. 10-year Treasury bonds plummeted 4.25% in today’s trading session. Remember, bond yields fall as prices go up.

Sponsored

Discover AI Stocks Potentially Ready to Skyrocket in Value!

With AI's predicted surge to $2 trillion in just 7 years, now might be the prime time to invest.

The most affluent future trillionaires?

Those who master AI, says Mark Cuban.

Don't miss out on our expertly curated list of the Top 5 AI Stocks set for potential monumental growth.

Act fast! Secure your FREE report now. Click Here!

Today's Market-Moving News 🔎 

📊 October CPI Recap: A Cooler Inflation Picture

Buckle up, number crunchers! The latest CPI scoop just landed, and guess what? It's holding steady, not budging an inch from September.

That's right, a big round zero change, defying the economist forecast of a 0.1% rise. Talk about a surprise twist!

📅 Yearly Snapshot 

When we zoom out to the past year, CPI did a bit of a climb - up by 3.2%. But hold on, that's still a notch below the predicted 3.3%. Seems like the inflation elevator isn't going as high as we thought.

🍽️ Core CPI Sans Drama

Stripping away the food and energy rollercoaster, core CPI clocked a 4% rise over 12 months. Close to the 4.1% expectation, but no cigar. It's like aiming for a bullseye and hitting just outside the red.

🏦 Fed's December Dilemma 

This CPI report drops a major clue before the Federal Reserve's next two-day meeting, which is set to wrap up on Dec. 13.

With numbers like these, the Fed's got some chewy decisions to make. Tighten policy, or take a breather? That's the multi-billion dollar question.

So, as the financial world holds its breath for the Fed's next move, today's CPI data paints a picture of an economy that's maybe, just maybe, starting to cool its jets on inflation.

BioCardia [BCDA] $1.07 (+168.1%) said the FDA approved a Phase III trial design for its CariAMP cell therapy for ischemic heart failure 

reAlpha Tech [AIRE] $12.00 (+103.7%) snapped a losing streak dating back to its Oct. 23rd IPO in a sudden reversal.

Turnstone Biologics [TSBX] $2.99 (+66.1%) rebounded from a slump that began after it reported its Q3 earnings last week.

Beauty Health [SKIN] $1.39 (64.3%) reported weaker-than-expected Q3 results, lowered its full-year guidance, and suspended its 2025 targets.  

Harrow Health [HROW] $8.21 (36.0%) reported a bigger Q3 loss than expected and missed Wall Street’s revenue target. 

Beyond Air [XAIR] $1.40 (31.0%) reported its Q3 earnings results yesterday, and Truist Securities slashed its price target on the stock from $14 to $10 in response to the report.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Text ELITE to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.